Summary
Pfizer Inc. (PFE) filed an 8-K report on April 28, 2009, to announce its financial results for the first quarter of 2009. The core of this filing is a press release, incorporated by reference, detailing the company's performance during the period. Investors should note that this 8-K primarily serves as a vehicle to furnish the Q1 2009 earnings press release. While the filing itself is brief, the attached press release contains the substantive financial and operational data. The press release, as the primary source of information, would have outlined key metrics such as revenue, earnings per share (EPS), and potentially guidance or commentary on future outlook, all crucial for understanding Pfizer's immediate financial health and trajectory.
Key Highlights
- 1Pfizer Inc. announced its first quarter 2009 financial results via an 8-K filing on April 28, 2009.
- 2The 8-K filing incorporates by reference a press release dated April 28, 2009, which contains the detailed financial information.
- 3This report serves as the official notification of Pfizer's Q1 2009 performance to the SEC and the investing public.
- 4Investors will need to refer to the press release (Exhibit 99) for specific financial figures and operational details.
- 5The filing date of April 28, 2009, indicates the results were released shortly after the quarter's close.
- 6The content of the press release is considered 'filed' under the Securities Exchange Act of 1934, making it material information.